glp-1-based therapy The Benefits of GLP-1 Therapy: Beyond Weight Loss GLP-1 Receptor Agonists for Obesity

Quad-agonists and even more complex multi-receptor compounds are already in preclinical development

CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS Effects of glp-/glucose-dependent insulinotropic peptide dual agonists on lipid metabolism GLP-/glucose-dependent insulinotropic peptide (GIP) dual agonists are a new type of oral hypoglycemic drug, which can activate both GLP-1 and GIP incretin at the same time, thereby exerting a more comprehensive blood glucose control effect [125]

You should use Saxenda according to the instructions your doctor gives you

In this Review, we summarize current preclinical and clinical evidence, showing that the riskbenefit profile of GLP1RAs remains favourable in individuals with T2DM and obesity, although caution is warranted in those with a low cardiometabolic risk, for whom the potential risks of cancer might outweigh any expected benefits

There were almost 23,000 cases during that period